Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

Overview of attention for article published in BioDrugs, May 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 646)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 162 Dimensions

Readers on

mendeley: 240 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 blog post.

CHMP recommends approval for rituximab biosimilar

HematologyTimes, 23 Apr 2017

Monoclonal antibodiesPhoto by Linda BartlettThe European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP…